Indianapolis-area hospitals have negotiated reimbursement rates with private health insurers that are two and three times higher than those paid by the federal Medicare program, suggesting the hospitals have the upper hand over insurers, according to a new study.
U.S. health insurers, including WellPoint Inc., can include the cost of federal taxes in determining whether they spend enough on patient care, the U.S. Health and Human Services Department said Tuesday.
Clarian Health has been growing faster than its peers in the Indianapolis market the past five years and is now generating healthy margins, according to a report this month by Moody’s Investors Service.
The Mishawaka-based health system’s move comes after months of consumer research—and six months after rival system Clarian Health said it would change its name to Indiana University Health.
L.H. Medical Corp. said it plans to create up to 65 jobs by 2013 and invest $5.4 million to more than triple the size of its manufacturing operations.
Les Zwirn, executive director of Better Healthcare for Indiana, talked about his group’s progress on promoting community collaborations to improve health and reduce the cost of care in cities around Indiana. BHI is hosting its third health care summit of Indiana community leaders today at Second Presbyterian Church in Indianapolis.
A 36-hour dance marathon raised about $1.6 million for Riley Hospital for Children in Indianapolis over the weekend.
Pharmaceutical firms led by Eli Lilly are trying to eliminate a government panel aimed at controlling Medicare spending seven months after they supported the health-care overhaul that created it.
Lilly paid $90 million in 2009 to acquire the global rights to the treatment in a bid to beef up its pipeline of medications for autoimmune diseases.
A federal audit recommends that Indiana's human services agency refund the federal government nearly $39 million it overpaid to Medicaid providers during a nine-year period.
Could nurse practitioners get a promotion in the medical field? At least one health insurer is treating them like doctors now.
Moody’s Investors Service on Monday lowered the long-term ratings of Lilly one notch, to A2 from A1, citing a wave of patent expirations the drugmaker faces in coming years.
A study at the Center for Health Policy at IUPUI found that 66 cents of every dollar the state spends on services related to substance abuse goes toward health care while only 1 cent goes toward prevention or intervention.
Eli Lilly said it will acquire Avid Radiopharmaceuticals, maker of an experimental agent that could help identify patients with Alzheimer’s disease. The price could climb to $800 million if the agent is commercially successful.
The Food and Drug Administration has cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back conditions, which could mean another $500 million in annual sales for Lilly, an analyst estimates.
In Utah, employers can give each of their workers a specific amount of money to apply toward health insurance. The worker then can use that money to choose from the 66 plans in the health insurance exchange.
Billboard companies spiked the cancer ad. But Citizens Gas or WellPoint might have gotten a different result.
Bill Styring, whose long, wonkish career includes analyzing health reform for Mike Pence, cried last night.
Jim Hamilton, an employee-benefits lawyer at Bose McKinney & Evans in Indianapolis, discussed the likelihood of a Republican-controlled U.S. House of Representatives changing or even outright repealing the health care reform law, formally known as the Patient Protection and Affordable Care Act.
Without an appeal, generic drugs are now poised to wipe away most of Lilly’s $750 million in annual U.S. revenue from Gemzar.
